Advertisement

International Journal of Clinical Pharmacy

, Volume 35, Issue 3, pp 439–446 | Cite as

Review of thromboembolic prophylaxis in patients attending Cork University Hospital

  • Stephen ByrneEmail author
  • Daniel Timothy Weaver
Research Article

Abstract

Background Although preventable, venous thromboembolism remains a common cause of hospital acquired morbidity and mortality. Guidelines, such as the one produced by the American College of Chest Physicians (ACCP), are aimed at reducing hospital associated venous thromboemboli. Unfortunately the majority of studies have revealed inadequate adherence to these guidelines. Objective The objective of this study was to evaluate the use of venous thromboembolism prophylaxis at Cork University Hospital. Setting Cork University Hospital, Wilton, Cork, Ireland. Methods Data from the patient’s chart, drug kardex and laboratory results were recorded during April 2010. A Caprini score, a venous thromboembolism risk factor assessment tool, was subsequently calculated for each patient based on data collected. Appropriate prophylaxis was determined after examining data collected, Caprini score and prophylactic regime according to the ACCP 8th edition guidelines. Main outcome measure Primary outcome was to analyse adherence to VTE prophylaxis guidelines. Results A total of 394 patients met the inclusion criteria and were reviewed, of which, 60 % (n = 236) were medical and 37 % (n = 146) were surgical patients. In total 63 % of patients received some form of venous thromboembolism prophylaxis. Furthermore, 54 % of medical and 76 % of surgical patients received prophylaxis. However only 37 % of the patients studied received appropriate thromboprophylaxis according to the ACCP 8th edition guidelines (Geerts et al. in chest 133(6 Suppl):381S–453S, 2008). Additionally 51 % of surgical and 27 % of medical patients received appropriate prophylaxis. Conclusion Data collected from Cork University Hospital revealed poor adherence to international venous thromboembolism prophylaxis guidelines. As stated in the ACCP 8th edition guidelines, every hospital should develop a formal strategy for venous thromboembolism prevention (Geerts et al. in chest 133(6 Suppl):381S–453S, 2008). In order to improve adherence to guidelines, Cork University Hospital should develop, implement and re-evaluate a specific protocol for venous thromboembolism prophylaxis.

Keywords

Guidelines Ireland Risk factors Thromboembolic prophylaxis Venous thromboembolism Venous thromboembolism prophylaxis 

Notes

Acknowledgments

The authors would like to thank all the patients and staff of Cork University Hospital.

Funding

There was no third party funding for this study.

Conflicts of interest

None to disclose.

References

  1. 1.
    Boon NA, Colledge NR, Walker BR, Hunter JAA, editors. Davidson’s principles and practice of medicine. 20th ed. London: Churchill Livingstone; 2006.Google Scholar
  2. 2.
    Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585–93.PubMedCrossRefGoogle Scholar
  3. 3.
    Baglin T. Venous thromboembolism in hospitalised patients: a public health crisis? Br J Haematol. 2008;141(6):764–70.PubMedCrossRefGoogle Scholar
  4. 4.
    Laffan M, Tuddenham E. Science, medicine, and the future: assessing thrombotic risk. BMJ. 1998;317(7157):520–3.PubMedCrossRefGoogle Scholar
  5. 5.
    Avorn J, Winkelmayer WC. Comparing the costs, risks, and benefits of competing strategies for the primary prevention of venous thromboembolism. Circulation. 2004;110(24 Suppl 1):IV25–32.PubMedGoogle Scholar
  6. 6.
    Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th Edition). Chest. 2008;133(6 Suppl):381S–453S.PubMedCrossRefGoogle Scholar
  7. 7.
    Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus group. BMJ. 1992; 305(6853):567–74.Google Scholar
  8. 8.
    Hill J, Treasure T. Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance. BMJ. 2010;340:c95.PubMedCrossRefGoogle Scholar
  9. 9.
    Caprini JA. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. Am J Surg. 2010;199(1 Suppl):S3–10.PubMedCrossRefGoogle Scholar
  10. 10.
    Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, et al. Prevention of venous thromboembolism. Chest. 2001;119(1 Suppl):132S–75S.PubMedCrossRefGoogle Scholar
  11. 11.
    Yu HT, Dylan ML, Lin J, Dubois RW. Hospitals’ compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm. 2007;64(1):69–76.PubMedCrossRefGoogle Scholar
  12. 12.
    Amin AN, Stemkowski S, Lin J, Yang G. Inpatient thromboprophylaxis use in US hospitals: adherence to the seventh American college of chest physician’s recommendations for at-risk medical and surgical patients. J Hosp Med. 2009;4(8):E15–21.PubMedCrossRefGoogle Scholar
  13. 13.
    Amin A, Spyropoulos AC, Dobesh P, Shorr A, Hussein M, Mozaffari E, et al. Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start). J Thromb Thrombolysis. 2010;29(3):326–39.PubMedCrossRefGoogle Scholar
  14. 14.
    Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371(9610):387–94.PubMedCrossRefGoogle Scholar
  15. 15.
    Vallano A, Arnau JM, Miralda GP, Perez-Bartoli J. Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study. Thromb J. 2004;2(1):3.PubMedCrossRefGoogle Scholar
  16. 16.
    Zeitoun AA, Dimassi HI, El Kary DY, Akel MG. An evaluation of practice pattern for venous thromboembolism prevention in Lebanese hospitals. J Thromb Thrombolysis. 2009;28(2):192–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Deheinzelin D, Braga AL, Martins LC, Martins MA, Hernandez A, Yoshida WB, et al. Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational and cross-sectional study in Brazil. J Thromb Haemost. 2006;4(6):1266–70.PubMedCrossRefGoogle Scholar
  18. 18.
    Ahmad HA, Geissler A, MacLellan DG. Deep venous thrombosis prophylaxis: are guidelines being followed? ANZ J Surg. 2002;72(5):331–4.PubMedCrossRefGoogle Scholar
  19. 19.
    Learhinan ER, Alderman CP. Venous thromboembolism prophylaxis in a South Australian teaching hospital. Ann Pharmacother. 2003;37(10):1398–402.PubMedCrossRefGoogle Scholar
  20. 20.
    Andrade Ede O, Binda FA, Silva AM, Costa TD, Fernandes MC. Risk factors and prophylaxis for venous thromboembolism in hospitals in the city of Manaus, Brazil. J Bras Pneumol. 2009;35(2):114–21.PubMedCrossRefGoogle Scholar
  21. 21.
    Shedd GC, Franklin C, Schumacher AM, Green DE. Improving inpatient venous thromboembolism prophylaxis. South Med J. 2008;101(12):1209–15.PubMedCrossRefGoogle Scholar
  22. 22.
    Caprini JA. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. Am J Surg [Journal Article]. 2010;199(1S):S3–10.CrossRefGoogle Scholar
  23. 23.
    Chopard P, Spirk D, Beer HJ, Peter J, Brunner B, Bounameaux H, et al. Swiss results from a global observational study of venous thromboembolism risk and prophylaxis use in the acute care hospital setting: analysis from the ENDORSE study. Swiss Med Wkly. 2009;139(43–44):630–5.PubMedGoogle Scholar
  24. 24.
    Musial J, Sydor WJ. Venous thromboembolism risk and prophylaxis in the acute hospital care setting—results of the ENDORSE study in Poland. Pol Arch Med Wewn. 2008;118(10):555–61.PubMedGoogle Scholar
  25. 25.
    Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005;51:70–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Hagg S, Jonsson AK, Spigset O. Risk of venous thromboembolism due to antipsychotic drug therapy. Expert Opin Drug Saf. 2009;8(5):537–47.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  1. 1.School of PharmacyUniversity College CorkCorkIreland
  2. 2.School of MedicineUniversity College CorkCorkIreland

Personalised recommendations